# A Study of FT1 in Healthy Adult Volunteers

> **NCT06610487** · PHASE1 · COMPLETED · sponsor: **Chongqing Peg-Bio Biopharm Co., Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Diarrhea Caused by Drug (Disorder)

## Interventions

- **DRUG:** FT1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06610487
- **Lead sponsor:** Chongqing Peg-Bio Biopharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-20
- **Primary completion:** 2025-08-08
- **Final completion:** 2025-08-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06610487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06610487, "A Study of FT1 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06610487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*